Scilex Holding Co financial data

Symbol
SCLX, SCLXW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
960 San Antonio Road, Palo Alto, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Scilex Holding Company/DE (to 11/30/2022), Vickers Vantage Corp. I (to 11/15/2022)
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 16.2 % -39.4%
Quick Ratio 1.09 % -48.3%
Debt-to-equity -148 % +34.3%
Return On Equity 36 % -75.3%
Return On Assets -74.8 % +35.5%
Operating Margin -147 % +34.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 243M shares +46.4%
Common Stock, Shares, Outstanding 183M shares +83.2%
Entity Public Float 233M USD -51.4%
Common Stock, Value, Issued 24K USD +50%
Weighted Average Number of Shares Outstanding, Basic 131M shares +0.64%
Weighted Average Number of Shares Outstanding, Diluted 134M shares +2.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 56.6M USD +21.1%
Cost of Revenue 16.7M USD +6.43%
Research and Development Expense 9.64M USD -24.4%
Operating Income (Loss) -83.4M USD +20.9%
Nonoperating Income (Expense) 15.5M USD +374%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -72.8M USD +36.3%
Income Tax Expense (Benefit) -1K USD -108%
Net Income (Loss) Attributable to Parent -72.8M USD +36.3%
Earnings Per Share, Basic -0.56 USD/shares +56.3%
Earnings Per Share, Diluted -0.61 USD/shares +52.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.27M USD -16.6%
Accounts Receivable, after Allowance for Credit Loss, Current 26.4M USD -23.6%
Inventory, Net 2.44M USD -42.2%
Assets, Current 41.5M USD -11.2%
Property, Plant and Equipment, Net 708K USD -1.94%
Operating Lease, Right-of-Use Asset 2.23M USD -24.4%
Intangible Assets, Net (Excluding Goodwill) 32.5M USD -11.1%
Goodwill 13.5M USD 0%
Assets 93M USD -8.25%
Accounts Payable, Current 52.6M USD +28.5%
Liabilities, Current 260M USD +3.7%
Operating Lease, Liability, Noncurrent 1.52M USD -31.9%
Other Liabilities, Noncurrent 155K USD -13.4%
Liabilities 286M USD +4.14%
Accumulated Other Comprehensive Income (Loss), Net of Tax 6.32M USD
Retained Earnings (Accumulated Deficit) -563M USD -14.9%
Stockholders' Equity Attributable to Parent -193M USD -11.4%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -193M USD -11.4%
Liabilities and Equity 93M USD -8.25%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 9.39M USD
Net Cash Provided by (Used in) Financing Activities -11.2M USD -205%
Net Cash Provided by (Used in) Investing Activities -150K USD
Common Stock, Shares Authorized 740M shares 0%
Common Stock, Shares, Issued 243M shares +52%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.96M USD -168%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.27M USD -30.8%
Deferred Tax Assets, Valuation Allowance 114M USD +17.5%
Deferred Tax Assets, Gross 117M USD +16.4%
Operating Lease, Liability 2.24M USD -25.3%
Depreciation 14K USD -65%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -1.23M USD +96.5%
Lessee, Operating Lease, Liability, to be Paid 2.58M USD -28.7%
Property, Plant and Equipment, Gross 772K USD -1.03%
Operating Lease, Liability, Current 714K USD -5.93%
Lessee, Operating Lease, Liability, to be Paid, Year Two 944K USD +3.06%
Lessee, Operating Lease, Liability, to be Paid, Year One 916K USD -12.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 347K USD -44.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 724K USD -23.3%
Deferred Tax Assets, Operating Loss Carryforwards 85.2M USD +19.3%
Preferred Stock, Shares Issued 29.1M shares 0%
Preferred Stock, Shares Authorized 45M shares 0%
Unrecognized Tax Benefits 1.2M USD +11.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 724K USD
Operating Lease, Payments 277K USD +28.2%
Additional Paid in Capital 455M USD +11.5%
Preferred Stock, Shares Outstanding 29.1M shares 0%
Amortization of Intangible Assets 4.03M USD -1.83%
Depreciation, Depletion and Amortization 1.03M USD -0.58%
Deferred Tax Assets, Net of Valuation Allowance 3M USD -14.2%
Share-based Payment Arrangement, Expense 15.7M USD +7.49%
Interest Expense 2.17M USD -77.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%